Skip to main content
. 2022 May 11;19(10):5863. doi: 10.3390/ijerph19105863

Table 3.

Pregnancy, birth, and neonatal Outcomes.

Treatment Effect
Control
Group a
Intervention Group a Adj. OR
(95% CI) b
Adj. Mean
Difference
(95% CI) b
Adj.
p-Value
Pregnancy and birth outcomes
Gestational diabetes mellitus 11.3% 12.4% 1.12 (0.77 to 1.63) 0.537
 Dietary treatment 4.0% 4.2% 1.05 (0.55 to 2.02) 0.876
 Insulin treatment 2.2% (n = 15) 1.9% (n = 15) c c
Bleeding 5.1% 2.6% 0.5 (0.23 to 1.10) 0.084
Gestational hypertension 2.4% (n = 16) 1.7% (n = 13) c c
Preterm birth 7.5% 9.4% 1.28 (0.69 to 2.36) 0.428
Caesarean section 31.6% 35.2% 1.19 (0.86 to 1.64) 0.301
Instrumental delivery 6.9% 7.9% 1.16 (0.68 to 1.96) 0.592
Neonatal outcomes
Birth weight, g 3329.7 3332.1 2.47 (−57 to 61.94) 0.935
Birth length, cm 51.5 51.4 −0.14 (−0.64 to 0.35) 0.572
LGA 5.9% 4.6% 0.76 (0.44 to 1.31) 0.320
SGA 8.5% 8.4% 1 (0.58 to 1.73) 0.993
Macrosomia
(birthweight > 4000 g)
10.3% 8.2% 0.76 (0.51 to 1.13) 0.172
Abnormal 5 min
Apgar-score (≤6)
2.1% (n = 12) 0.5% (n = 3) c c

a Estimated shares/means; in cases of small number of cases, no model-based estimations could be obtained and raw shares are displayed in italics. b Adjusted for prepregnancy BMI, parity, age, migration status, and educational level. c No statistical modeling due to small number of cases.